Vitron-C 125 mg / 65 mg Delayed Release Oral Tablet
RxNorm 352160
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 352160 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Vitron-C 125 mg / 65 mg Delayed Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Ascorbic acid 125 mg / ferrous fumarate 200 mg Delayed Release Oral Tablet [Vitron-C]
(Atom ID: 12369080)
SY
Synonym (SY):
Vit-C 125 mg / Ferrous fumarate 200 mg Delayed Release Oral Tablet [Vitron-C]
(Atom ID: 6338219)
SY
Synonym (SY):
Vitamin C 125 mg / Ferrous fumarate 200 mg Delayed Release Oral Tablet [Vitron-C]
(Atom ID: 6338077)
SY
Synonym (SY):
Vitron-C (ascorbic acid 125 mg / ferrous fumarate 200 mg) Delayed Release Oral Tablet
(Atom ID: 6338217)
SY
Synonym (SY):
Vitron-C (ferrous fumarate 200 mg / vitamin C 125 mg) Delayed Release Oral Tablet
(Atom ID: 6338218)
PSN